KATIE MYSEN: Open Payments
NPI 1699081281 · OXFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 11 payments from 7 companies in 2025. Trend: 2023 $237 · 2024 $319 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 1 | $75 |
| Lilly USA, LLC | 2 | $33 |
| Biogen, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: INGREZZA, VRAYLAR, MOUNJARO, SPINRAZA, The Cologuard Plus Collection Kit, QULIPTA, UBRELVY, Qelbree.
Industry payments across MI — which companies pay providers there.
